Your browser doesn't support javascript.
loading
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
Duault, Caroline; Kumar, Anil; Taghi Khani, Adeleh; Lee, Sung June; Yang, Lu; Huang, Min; Hurtz, Christian; Manning, Bryan; Ghoda, Lucy; McDonald, Tinisha; Lacayo, Norman J; Sakamoto, Kathleen M; Carroll, Martin; Tasian, Sarah K; Marcucci, Guido; Yu, Jianhua; Caligiuri, Michael A; Maecker, Holden T; Swaminathan, Srividya.
Afiliación
  • Duault C; The Human Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA.
  • Kumar A; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA.
  • Taghi Khani A; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA.
  • Lee SJ; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA.
  • Yang L; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA.
  • Huang M; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Hurtz C; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Manning B; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Ghoda L; Department of Hematological Malignancies and Translational Science, Beckman Research Institute of City of Hope, Duarte, CA.
  • McDonald T; Department of Hematological Malignancies and Translational Science, Beckman Research Institute of City of Hope, Duarte, CA.
  • Lacayo NJ; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Sakamoto KM; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Carroll M; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; and.
  • Marcucci G; Department of Hematological Malignancies and Translational Science, Beckman Research Institute of City of Hope, Duarte, CA.
  • Yu J; Department of Hematology and Hematopoietic Stem Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, CA.
  • Caligiuri MA; Department of Hematology and Hematopoietic Stem Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, CA.
  • Maecker HT; The Human Immune Monitoring Center, Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA.
  • Swaminathan S; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA.
Blood ; 138(16): 1465-1480, 2021 10 21.
Article en En | MEDLINE | ID: mdl-34077953
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Activación de Linfocitos / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Activación de Linfocitos / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Año: 2021 Tipo del documento: Article